You are here Journals » Neuropsychiatric Disease and Treatment » Volume 6 » Issue 1

Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients

Total article views   HTML views PDF downloads Totals
21,028 Dovepress* 16,461 2,817 19,278
PubMed Central* 4,567 871 5,438
Totals 21,028 3,688 24,716
*Since 10 November 2010
+Since July 2016

View citations on PubMed and Google Scholar